Home » Newsletters » BioWorld Science

BioWorld Science

March 11, 2011

View Archived Issues

Carnosic acid is neuroprotective in rat model of Alzheimer's disease

UCB reviews pipeline progress of 2010

NeuroDerm advances phase I/II trial of ND-0611 dermal patch for Parkinson's disease

Genus Oncology's GO-203-2c receives FDA orphan drug status in pancreatic cancer

Novel putative biomarkers for endometrial ovarian carcinoma identified

Aerie Pharma secures financing to support advancement of glaucoma portfolio

First-in-human data on TUTI-16 support its use in asymptomatic HIV-1-infected subjects

Cell Therapeutics reports final design of pivotal pixantrone trial

Merck & Co. presents novel renin inhibitors

Phenex Pharma patents new farnesoid X receptor agonists

PharmaMar reports novel inhibitors of HIV reverse transcriptase

Novartis presents novel inhibitors of hepatocyte growth factor receptor

Sinovac Biotech submits application for pneumococcal conjugate vaccine trials in China

Plexxikon begins phase II trial of PLX-3397 in Hodgkin's lymphoma

FDA accepts Merck & Co.'s tafluprost NDA to treat elevated intraocular pressure

Boehringer Ingelheim patents new phosphodiesterase 9A inhibitors

Enrollment complete in ERYtech Pharma's phase II Graspa trial in acute lymphoblastic leukemia

Santarus begins phase I trial of SAN-300 for rheumatoid arthritis

Adamis Pharma files IND with FDA for APC-100 in prostate cancer

Roche reports on new gamma-secretase modulators for treatment of Alzheimer's disease

Genentech reports moderate to low risk of interactions between GDC-0941 and paclitaxel

Insys Therapeutics submits NDA to FDA for fentanyl sublingual spray

Eisai and Epizyme enter worldwide partnership for EZH2-targeting anticancer therapeutics

Vertex Pharma plans phase IIb VX-765 trial in epilepsy following phase IIa data

Biothera acquires Antisoma's anticancer monoclonal antibody AS-1402

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...